The global demand for aortic stents graft market was valued at 1934.90 USD MN in 2022 and is expected to generate revenue of 3168.73 USD MN in 2030, growing at a CAGR of 6.36% between 2023 and 2030
An aortic stent graft is a new option for treatment of aneurysm, which is also known as endovascular stent graft (EVAR). In this therapy, EVAR stent graft fits inside the aorta aneurysm with help of delivery catheter tube to protect the aneurysm from rupturing and also create a safe tunnel through which blood can pass. This is minimally invasive procedure with typically performed under local, regional or general anesthesia. This stent graft therapy reduces recovery time to a few days and greatly reduces time in the hospital. Increase in the number of aortic aneurysm patient population and government screening programs for population is anticipated to fuel the overall growth of the global aortic stent graft market.
Market Dynamics
Rising prevalence of aortic aneurysms, growing preference of minimally invasive surgeries, and adoption of endovascular aneurysm repair (EVAR) over open surgical repair are the key factors that drive the market demand. In addition to this, increasing awareness about aneurysms, rising demand for minimally invasive procedure, geriatric population and rising incidences of diseases (obesity and diabetes) is expected to propel the market growth during the forecast period. Though, emerging technology in stent graft design including fenestrated and branched endografts is anticipated to create potential opportunities for aortic stents grafts market in the coming year. However, high cost of aortic stent graft devices may hamper the market growth.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each product and end-user segment in the global market of aortic stents grafts.
Market Segmentation
The entire aortic stents grafts market has been sub-categorized into product and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Product
- Abdominal Aortic Stent Graft
- Thoracic Aortic Stent Graft
By End User
- Hospitals
- Ambulatory Surgical Centers/Outpatient Surgical Centers
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for aortic stents grafts market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Aortic Stents Grafts Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the aortic stents grafts market include Cook Medical, Inc., W.L. Gore & Associates, MicroPort Scientific Corporation Inc., Medtronic Plc., Lombard Medical, Inc., Endologix, INC., Terumo Corporation Inc., Cardinal Health Inc., Becton, Dickinson and Company, Cryolife Inc., and Lombard Medical Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.